« Previous
Next »
American Journal of Kidney Diseases
Volume 54, Issue 4
, Pages
619-637
, October 2009
Benefits and Harms of Phosphate Binders in CKD: A Systematic Review of Randomized Controlled Trials
-
Effect of phosphate binders on end-of-treatment serum phosphorus concentration in people with chronic kidney disease. Conversion factor for phosphorus in mg/dL to mmol/L, ×0.3229. Abbreviation: CI, co
Effect of phosphate binders on end-of-treatment serum phosphorus concentration in people with chronic kidney disease. Conversion factor for phosphorus in mg/dL to mmol/L, ×0.3229. Abbreviation: CI, confidence interval.
-
Effect of phosphate binders on end-of-treatment parathyroid hormone concentration (pg/mL) in people with chronic kidney disease. Parathyroid hormone in pg/mL and ng/L requires no conversion. AbbreviatEffect of phosphate binders on end-of-treatment parathyroid hormone concentration (pg/mL) in people with chronic kidney disease. Parathyroid hormone in pg/mL and ng/L requires no conversion. Abbreviation: CI, confidence interval.
Originally published online as doi:10.1053/j.ajkd.2009.06.004 on August 19, 2009.
This review is excerpted from a Cochrane Review to be published in The Cochrane Library (http://www3.interscience.wiley.com/cgi-bin/mrwhome/106568753/HOME). Cochrane Reviews are regularly updated as new evidence emerges in response to comments and criticisms, and The Cochrane Library should be consulted for the most recent version of the review.
PII: S0272-6386(09)00865-8
doi: 10.1053/j.ajkd.2009.06.004
© 2009 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
American Journal of Kidney Diseases
Volume 54, Issue 4
, Pages
619-637
, October 2009
